MONTEFIORE MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.montefiore.org

Clinical Trials

Detemir: Role in Type 1 Diabetes

Phase 4

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: Insulin Detemir mixed with RAI injection
Drug: Insulin Detemir and RAI injection

First Posted Date: 2007-11-28

Last Posted Date: 2018-07-17

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 18

Registration Number: NCT00564395

Locations: 🇺🇸
Texas Children's Hospital Endocrine and Diabetes Clinic, Houston, Texas, United States

Evaluation of CHAM JAM Increasing Physical Activity Levels in Students

Not Applicable

Completed

Conditions: Physical Activity
Obesity

Interventions: Other: CHAM JAM

First Posted Date: 2007-11-12

Last Posted Date: 2018-02-22

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 10098

Registration Number: NCT00556569

Locations: 🇺🇸
4 Elementary Schools, Bronx, New York, United States

Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults

Phase 2

Completed

Conditions: Juvenile Idiopathic Arthritis

Interventions: Biological: Rilonacept

First Posted Date: 2007-09-26

Last Posted Date: 2015-12-11

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 71

Registration Number: NCT00534495

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

The Efficacy of EMLA Cream vs. Synera Patch for Pain Reduction During Venipuncture in Children

Phase 2

Completed

Conditions: Pain
Needle Phobia

Interventions: Drug: EMLA Cream
Combination Product: Synera Patch

First Posted Date: 2007-09-17

Last Posted Date: 2018-08-31

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 100

Registration Number: NCT00530803

Locations: 🇺🇸
Children's Hospital at Montefiore, Bronx, New York, United States

The Montefiore Metoclopramide Study

Phase 4

Completed

Conditions: Nausea
Extrapyramidal Symptoms

Interventions: Drug: Diphenhydramine 25 mg
Drug: Placebo
Drug: metoclopramide 10 mg
Drug: Metoclopramide 20 mg

First Posted Date: 2007-05-21

Last Posted Date: 2012-12-31

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 289

Registration Number: NCT00475306

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Role of Exenatide in Type 1 Diabetes

Phase 2

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Exenatide
Drug: Insulin

First Posted Date: 2007-04-04

Last Posted Date: 2019-02-26

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 11

Registration Number: NCT00456300

Locations: 🇺🇸
Texas Children's Hospital/ Baylor College of Medicine, Houston, Texas, United States

Comparing Naproxen to Sumatriptan for Emergency Headache Patients

Phase 4

Completed

Conditions: Migraine
Tension-type Headache
Primary Headache Disorder

Interventions: Drug: Sumatriptan 100 mg
Drug: Naproxen

First Posted Date: 2007-03-21

Last Posted Date: 2018-05-31

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 401

Registration Number: NCT00449787

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus

Phase 4

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: Pramlintide + Insulin
Drug: Insulin

First Posted Date: 2007-03-02

Last Posted Date: 2018-07-10

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 8

Registration Number: NCT00442767

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor

Completed

Conditions: HIV Infections

First Posted Date: 2007-02-08

Last Posted Date: 2018-04-27

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 45

Registration Number: NCT00432783

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients

Phase 1

Terminated

Conditions: Hypercalcemia
Secondary Hyperparathyroidism

Interventions: Drug: Cinacalcet HCl

First Posted Date: 2006-12-25

Last Posted Date: 2021-04-23

Lead Sponsor: Montefiore Medical Center

Target Recruit Count: 18

Registration Number: NCT00415584

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy